advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (23)
Showing records 1 to 23
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation46458 Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Skalicky SE; Goldberg I; McCluskey P
American Journal of Ophthalmology 2011;
46941 About ocular surface damage
Stefan C; Pop A; Cojocaru I
Oftalmologia 2011; 55: 38-40
46956 Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
Journal of oleo science 2010; 59: 423-430
46746 Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Erb C; Lanzl I; Seidova S-F; Kimmich F
Advances in Therapy 2011; 1-11
46375 Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy
Kitazawa Y; Smith P; Sasaki N; Kotake S; Bae K; Iwamoto Y
Eye 2011; 25: 1161-1169
47012 Benzalkonium chloride in glaucoma medications
Noecker R; Miller KV
Ocular Surface 2011; 9: 159-162
46668 Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martinez IT; Young MJ; Herrero-Vanrell R
Journal of Controlled Release 2011;
47008 Nanovesicular Formulation of Brimonidine Tartrate for the Management of Glaucoma: In Vitro and In Vivo Evaluation
Maiti S; Paul S; Mondol R; Ray S; Sa B
AAPS PharmSciTech 2011;
46997 Evaluation of the ocular penetration of topical alpha-luminol (Galavit((registered trademark))/GVT((registered trademark)))
da Silva EG; Gionfriddo JR; Hudachek SF; Gustafson DL; Olea-Popelka FJ; Scofield VL; Powell CC; Hill AE
Veterinary Ophthalmology 2011; 14: 180-185
46781 Thermosensitive in situ gel of Timolol Maleate for the treatment of open angle glaucoma
Yeole PG; Iyer D
Research Journal of Pharmaceutical, Biological and Chemical Sciences 2011; 2: 1048-1064
46778 Formulation and evaluation of dorzolamide hydrochloride polymeric film
Tandale YN; Wagh VD
International Journal of PharmTech Research 2011; 3: 1817-1824
47009 Brimonidine Tartrate-Eudragit Long-Acting Nanoparticles: Formulation, Optimization, In Vitro and In Vivo Evaluation
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech 2011;
46330 Managing treatment side effects: the respective roles of the active ingredient and the preservative
Aptel F; Denis P; Baudouin C
Journal Français d'Ophtalmologie 2011; 34: 409-412
47011 Preservative use in topical glaucoma medications
Tressler CS; Beatty R; Lemp MA
Ocular Surface 2011; 9: 140-158
46555 Prescribing for older adults
Boparai MK; Korc-Grodzicki B
Mount Sinai Journal of Medicine 2011; 78: 613-626
46441 Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models
Kadam RS; Cheruvu NP; Edelhauser HF; Kompella UB
Investigative Ophthalmology and Visual Science 2011; 52: 5387-5399
46863 Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells
Ammar DA; Kahook MY
Molecular Vision 2011; 17: 1806-1813
46889 Drug delivery to the posterior segment of the eye
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
European Journal of Ophthalmology 2011; 21: 20-26
46720 In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment
Natu MV; Gaspar MN; Fontes Ribeiro CA; Cabrita AM; De Sousa HC; Gil MH
International Journal of Pharmaceutics 2011; 415: 73-82
46926 Benzalkonium chloride daily dose - An important criterion in glaucoma treatment
Vyborny P; Sicakova S
Česka a Slovenska Oftalmologie 2011; 67: 63-66
46570 An in vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)
Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
Yakugaku Zasshi 2011; 131: 985-991
46844 Symptoms and signs of tear film dysfunction in glaucomatous patients
Valente C; Iester M; Corsi E; Rolando M
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 281-285
46451 A Video Study of Drop Instillation in Both Glaucoma and Retina Patients with Visual Impairment
Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
American Journal of Ophthalmology 2011;
